Bank of New York Mellon’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
N
Bank of New York Mellon's ELV Position: Q2 2026 in Review
Bank of New York Mellon increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $140M and bringing the position to 3,222,787 shares worth $1.25B. The position accounts for 0.2% of the portfolio, ranked #87.
Bank of New York Mellon first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. 1,181 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Bank of New York Mellon held 3,222,787 shares of Elevance Health worth $1.25B as of Q2 2026.
- Bank of New York Mellon bought 377,507 Elevance Health shares in Q2 2026, an estimated $140M.
- Elevance Health made up 0.2% of Bank of New York Mellon's portfolio in Q2 2026, its #87 holding.
- Bank of New York Mellon first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- 1,181 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.